Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Drazen

Showing results (11-20 of 329) with videos related to

Pageof 33
Sort By:
Pharmacotherapy|January 1, 1997
Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthmaJ M Drazen
The New England Journal of Medicine|November 30, 2000
To protect those who serveJ M Drazen, G Koski
The New England Journal of Medicine|June 9, 2001
AIDS--will the next 20 years be different?R Steinbrook, J M Drazen
International Archives of Allergy and Immunology|May 1, 1995
Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathwayJ M Drazen, E Israel
The New England Journal of Medicine|September 15, 1994
Treating mild asthma--when are inhaled steroids indicated?E Israel, J M Drazen
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? YesJ M Drazen, E Israel
The New England Journal of Medicine|June 8, 1989
Reversing the irreversibleJ M Drazen, C Gerard
Lancet (London, England)|June 17, 1999
Churg-Strauss syndromeM Wechsler, J M Drazen
The American Review of Respiratory Disease|October 1, 1991
Asthma: a solution to half the puzzle?J M Drazen, E Israel
Proceedings of the Association of American Physicians|December 11, 1999
The biology of 5-lipoxygenase: function, structure, and regulatory mechanismsE S Silverman, J M Drazen
Pageof 33

Showing results (11-20 of 329) with videos related to

Sort By:
Pageof 33
Pharmacotherapy|January 1, 1997
Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthmaJ M Drazen
The New England Journal of Medicine|November 30, 2000
To protect those who serveJ M Drazen, G Koski
The New England Journal of Medicine|June 9, 2001
AIDS--will the next 20 years be different?R Steinbrook, J M Drazen
International Archives of Allergy and Immunology|May 1, 1995
Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathwayJ M Drazen, E Israel
The New England Journal of Medicine|September 15, 1994
Treating mild asthma--when are inhaled steroids indicated?E Israel, J M Drazen
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? YesJ M Drazen, E Israel
The New England Journal of Medicine|June 8, 1989
Reversing the irreversibleJ M Drazen, C Gerard
Lancet (London, England)|June 17, 1999
Churg-Strauss syndromeM Wechsler, J M Drazen
The American Review of Respiratory Disease|October 1, 1991
Asthma: a solution to half the puzzle?J M Drazen, E Israel
Proceedings of the Association of American Physicians|December 11, 1999
The biology of 5-lipoxygenase: function, structure, and regulatory mechanismsE S Silverman, J M Drazen
Pageof 33